Literature DB >> 21622220

Serine phosphorylation of the Stat5a C-terminus is a driving force for transformation.

Katrin Friedbichler1, Andrea Hoelbl, Geqiang Li, Kevin D Bunting, Veronika Sexl, Fabrice Gouilleux, Richard Moriggl.   

Abstract

Persistent tyrosine phosphorylation of Stat3 and Stat5 is associated with oncogenic activity. Phosphorylation of the conserved tyrosine residue (pTyr) was long believed to be the only essential prerequisite to promote activation and nuclear translocation of Stat proteins. It has become evident, however, that post-translational protein modifications like serine phosphorylation, acetylation, glycosylation as well as protein splicing and processing constitute further regulatory mechanisms to modulate Stat transcriptional activity and to provide an additional layer of specificity to Jak-Stat signal transduction. Significantly, most vertebrate Stat proteins contain one conserved serine phosphorylation site within their transactivation domains. This phosphorylation motif is located within a P(M)SP sequence. Stat transcription factor activity is negatively influenced by mutation of the serine to alanine. Moreover, it was shown for both Stat3 and Stat5 that their capacity to transform cells was diminished. This review addresses recent advances in understanding the regulation and the biochemical and biological consequences of Stat serine phosphorylation. In particular, we discuss their role in persistently activated Stat proteins for cancer research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622220     DOI: 10.2741/3897

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  6 in total

1.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

2.  Acetylation and sumoylation control STAT5 activation antagonistically.

Authors:  Oliver H Krämer; Richard Moriggl
Journal:  JAKSTAT       Date:  2012-07-01

3.  Stat3 and Socs3 expression patterns during murine placenta development.

Authors:  S San Martin; J S Fitzgerald; M Weber; M Párraga; T Sáez; T M Zorn; U R Markert
Journal:  Eur J Histochem       Date:  2013-06-28       Impact factor: 3.188

Review 4.  Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.

Authors:  Angelika Berger; Veronika Sexl; Peter Valent; Richard Moriggl
Journal:  Oncotarget       Date:  2014-10-30

5.  How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5.

Authors:  Florent Langenfeld; Yann Guarracino; Michel Arock; Alain Trouvé; Luba Tchertanov
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

6.  Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.

Authors:  Manel Benhassine; Gaëtan Le-Bel; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.